Skip to content
Search AI Powered

Latest Stories

RPS and Pharmacy Support join hands for pharmacy professionals wellbeing

RPS and Pharmacy Support join hands for pharmacy professionals wellbeing
Marks a significant milestone in the pharmacy sector's commitment to nurturing its pharmacy family

The Royal Pharmaceutical Society (RPS) and Pharmacist Support have announced a formal agreement aimed at enhancing collaboration to better support RPS members and increase the impact of the charity.

This partnership comes after years of working closely together, and formalising it will allow both organisations to reach a wider audience and focus on supporting the wellbeing of pharmacy professionals.


The aim of the partnership is to establish a visible link between the professional body and the independent charity to increase awareness about the two organisations for greater focus on the support within the sector.

Along with this, the key objectives also include identifying fundraising opportunities for Pharmacist Support, and collaborating on specific wellbeing projects.

RPS Chief Executive Paul Bennett emphasised the shared commitment to advancing the profession and supporting members, stating that the agreement strengthens existing collaboration and "opens avenues for deeper engagement and joint initiatives to empower pharmacists and contribute to the wellbeing of pharmacy professionals.”

Chief Executive of Pharmacist Support, Danielle Hunt, echoed these sentiments, highlighting the partnership as a significant milestone in supporting the pharmacy family.

She emphasised the collaboration's role in advancing the wellbeing of pharmacists and their families, building on initiatives like workforce wellbeing surveys and roundtable events.

Hunt expressed excitement about officially joining forces and working together to bring about a cultural shift that enhances sector wellbeing.

Additionally, she looks forward to furthering fundraising activities with the RPS and its members to ensure continued support for "the pharmacy family".

The formalisation of this partnership signifies a strategic move to align efforts and resources, ultimately benefiting pharmacy professionals and advancing the profession as a whole.

With a renewed focus on collaboration and shared objectives, the RPS and Pharmacist Support are poised to make a meaningful impact on the wellbeing of the pharmacy sector.

More For You

Sigma Conference: "Pharmacists need greater role in integrated care boards," says CPE representative

Prakash Patel was speaking at a panel discussion at the Sigma Conference

Sigma Conference: "Pharmacists need greater role in integrated care boards," says CPE representative

Pharmacists need to be a part of integrated care boards (ICB) to stop GPs from monopolising services based on their needs rather than the needs of the patient, according to Prakash Patel, Community Pharmacy Engaland (CPE) representative for North London.

“The evolution of the NHS should mean there can be no decision of pharmacy without pharmacist,” Patel told delegates at the Sigma Pharmacy Conference in Baku, Azerbaijan on Tuesday.

Keep ReadingShow less
David Webb
David Webb, NHS England's Chief Pharmaceutical Officer
David Webb, NHS England's Chief Pharmaceutical Officer

Sigma Conference: "Community pharmacy ready to make a profound contribution to 10 Year Health Plan," says David Webb

A national community pharmacy prescribing service remains a long-term goal of the government, according to NHS chief pharmaceutical officer, David Webb.

The Labour Party in its election manifesto last year said it would “create a Community Pharmacist Prescribing Service, granting more pharmacists independent prescribing rights”.

Keep ReadingShow less
Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less